Technical Analysis for NRC - National Research Corporation

Grade Last Price % Change Price Change
F 19.07 1.71% 0.32
NRC closed down 0.42 percent on Wednesday, November 20, 2024, on 1.34 times normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
1 Watcher
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down

Date Alert Name Type % Chg
MACD Bearish Signal Line Cross Bearish 1.71%
NR7 Range Contraction 1.71%
Narrow Range Bar Range Contraction 1.71%
Fell Below 20 DMA Bearish 3.25%
MACD Bearish Centerline Cross Bearish -0.37%
Crossed Above 20 DMA Bullish -0.37%
Narrow Range Bar Range Contraction -0.37%
Inside Day Range Contraction -0.37%
Fell Below 20 DMA Bearish 0.53%
Fell Below 50 DMA Bearish 0.53%

   Recent Intraday Alerts

Alert Time
Rose Above Previous Day's High 4 minutes ago
20 DMA Resistance 4 minutes ago
Outside Day 4 minutes ago
Up 2% 4 minutes ago
Up 1% 4 minutes ago

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

National Research Corporation Description

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience in the United States and Canada. Its portfolio of subscription-based solutions provide actionable information and analysis to healthcare organizations and payers across a range of mission-critical, constituent-related elements, including patient experience, satisfaction, community population health risks, workforce engagement, community perceptions, and physician engagement. The company offers market insights solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. It also provides experience solutions, such as patient and resident experience, workforce engagement, health risk assessments, transitions, and improvement tools. The company offers transitions solutions, which enable organizations to identify and manage high-risk patients to reduce readmissions, increase patient satisfaction and support safe care transitions; and risk assessment solutions that enable clients to segment populations and manage care for those who are most at risk, engage individuals, enhance preventative care, and manage wellness programs. It provides transparency solutions that allow healthcare organizations to share picture of their organization and ensure content informs in consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. The company serves integrated health systems and post-acute providers, such as home health, long term care, hospice, and payer organizations. The company was founded in 1981 and is headquartered in Lincoln, Nebraska.


Classification

Sector: Healthcare
Industry: Diagnostics & Research
Keywords: Health Systems Healthcare Organizations Hospice Risk Assessment Long Term Care Healthcare Brands

Is NRC a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 41.608
52 Week Low 17.62
Average Volume 74,073
200-Day Moving Average 27.42
50-Day Moving Average 19.98
20-Day Moving Average 19.06
10-Day Moving Average 19.61
Average True Range 0.77
RSI (14) 44.75
ADX 22.61
+DI 24.93
-DI 22.63
Chandelier Exit (Long, 3 ATRs) 19.32
Chandelier Exit (Short, 3 ATRs) 19.94
Upper Bollinger Bands 21.01
Lower Bollinger Band 17.10
Percent B (%b) 0.42
BandWidth 20.51
MACD Line -0.17
MACD Signal Line -0.14
MACD Histogram -0.025
Fundamentals Value
Market Cap 460.47 Million
Num Shares 24.6 Million
EPS 1.16
Price-to-Earnings (P/E) Ratio 16.16
Price-to-Sales 6.35
Price-to-Book 16.33
Dividend 0.48
Dividend Yield 2.56%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 19.26
Resistance 3 (R3) 19.28 19.12 19.18
Resistance 2 (R2) 19.12 18.99 19.12 19.15
Resistance 1 (R1) 18.94 18.91 18.86 18.92 19.12
Pivot Point 18.78 18.78 18.75 18.78 18.78
Support 1 (S1) 18.60 18.65 18.52 18.58 18.38
Support 2 (S2) 18.44 18.57 18.44 18.35
Support 3 (S3) 18.26 18.44 18.33
Support 4 (S4) 18.24